Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
Author:
Publisher
Elsevier BV
Subject
General Materials Science
Reference82 articles.
1. Chronic myeloid leukemia: a historical perspective;Goldman;Semin Hematol,2010
2. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected];Fukuoka;J Clin Oncol,2003
3. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib;Kobayashi;N Engl J Med,2005
4. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS);Fukuoka;J Clin Oncol,2011
5. A new initiative on precision medicine;Collins;N Engl J Med,2015
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mitochondrial Fraction of Circulating Cell-Free DNA as an Indicator of Human Pathology;International Journal of Molecular Sciences;2024-04-10
2. The Potential of Cell-Free DNA in Cancer: towards Standardization and Optimization for Enhanced Diagnosis and Monitoring;J BIOL REG HOMEOS AG;2024
3. Early prognosis prediction in acute myeloid and acute lymphoid leukemia patients using cell-free DNA concentration ratios;Frontiers in Molecular Biosciences;2024-01-22
4. Overview of the role of liquid biopsy in cancer management;Translational Oncology;2023-08
5. Molecular Characterization of Single Circulating Tumor Cells in Breast and Ovarian Cancer;Circulating Tumor Cells;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3